Which countries run stem-cell trials for Spinal Cord Injury?

Country distribution

A study with sites in several countries is counted once per country, taken from the location block of each registry record.

What the map means for Spinal Cord Injury

Registered work sits in neurosurgical and rehabilitation centres with standardised ASIA examination capability. Commercial offers for chronic injury are widespread internationally and generally do not report examinations to that standard.

Where recruitment is actually open

What travelling for a trial actually involves

Cross-border participation fails on logistics more often than on eligibility: follow-up schedules, local insurance, visa duration and who pays for complications. A site that cannot answer those in writing is not going to enrol you.

Multi-country studies, named

Registered studies with sites in more than one country — the clearest evidence of collaboration rather than a single-centre series.

• NCT05018793 — Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cor (Antigua and Barbuda, Greece)
• NCT05152290 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI (Antigua and Barbuda, Greece)
• NCT02795052 — Neurologic Stem Cell Treatment Study (United Arab Emirates, United States)
• NCT03935724 — Stem Cells in Spinal Cord Injury (Denmark, Spain)

Why trial geography is not a shortlist

Where studies happen reflects who funds and who authorises them. Treating that as a ranking of care quality confuses the research system with the treatment market, two things that overlap far less than medical-tourism marketing implies.

Before treating geography as a shortlist, read the legality overview by country and what "best country" actually means here.

When these studies started

Registrations by start year since 2020: 2020 (2), 2021 (1), 2022 (4), 2023 (1), 2024 (1), 2025 (5), 2026 (1), 2028 (1). Activity for this condition spans 2006 to 2028, which shows whether interest is growing, flat or past its peak.

Frequently asked

Which countries run stem-cell trials for Spinal Cord Injury?

Sites are registered in 19 countries; the largest is United States (~26% of country mentions, 2026-08-29).

Does a country with many trials mean better treatment there?

It does not follow. A country can host many trials and still have an unregulated commercial sector selling something quite different to visitors.

Are trial sites and commercial clinics the same thing?

Usually not. The hospital running a registered study is often unrelated to clinics marketing treatments to international patients in the same city.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.